Atlas Trials

Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules

Clinical trial NCT02027662 · COMPLETED

Trial details

NCT number
NCT02027662
Sponsor
Fresenius Medical Care Deutschland GmbH
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HyperphosphatemiaChronic Kidney Disease
Start date
2014-01-01
Primary completion
2015-04-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.